Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oceania HealthcareASX:OCA +2.46%39 EV-to-EBIT is 56.26 as of Jul. 29, 2026, which is 240% above its 10-year median of 16.57. GuruFocus rates ASX:OCA with a GF Score™ of 39/100 and a GF Value™ of A$0.80 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Oceania Healthcare ranks worse than 90.02% on this metric.
The historical rank and industry rank for Oceania Healthcare's EV-to-EBIT or its related term are showing as below:
ASX:OCA'
s EV-to-EBIT Range Over the Past 10 Years
Min: -56.31 Med: 16.57 Max: 61.67
Current: 59.79
During the past 9 years, the highest EV-to-EBIT of Oceania Healthcare was 61.67. The lowest was -56.31. And the median was 16.57.
ASX:OCA's EV-to-EBIT is ranked worse than 90.02% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.74
vs ASX:OCA: 59.79
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Oceania Healthcare's Enterprise Value for the quarter that ended in Mar. 2026 was A$895.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oceania Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$15.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oceania Healthcare EV-to-EBIT Related Terms
Oceania Healthcare EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Oceania Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Oceania Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oceania Healthcare EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Oceania Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Oceania Healthcare's EV-to-EBIT falls into.
Oceania Healthcare's current Enterprise Value is A$863.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oceania Healthcare's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$15.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oceania Healthcare (ASX:OCA) has a EV-to-EBIT of 56.26 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Oceania Healthcare and its competitors. This is 240% above median its historical median of 16.57. According to the industry distribution chart, Oceania Healthcare ranks #424 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 90%.
Is Oceania Healthcare's EV-to-EBIT too high?
Oceania Healthcare's current EV-to-EBIT of 56.26 is 240% above median its 10-year median of 16.57. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Oceania Healthcare's value of 56.26 is 257.4% above this industry median. Based on the distribution chart, Oceania Healthcare ranks #424 out of 471 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Oceania Healthcare has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oceania Healthcare's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Oceania Healthcare ranks #424 out of 471 companies for EV-to-EBIT. This places Oceania Healthcare in the lower half of its industry. The industry median EV-to-EBIT is 15.74. Oceania Healthcare's value of 56.26 is 257.4% above this benchmark. While the company's 10-year median is 16.57 vs. the industry median of 15.74, Oceania Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oceania Healthcare's current EV-to-EBIT of 56.26 is 257.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Oceania Healthcare and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oceania Healthcare's current EV-to-EBIT is 56.26, which is 240% above median its own 10-year median of 16.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oceania Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Oceania Healthcare (ASX:OCA) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.80, compared to a current price of A$0.63 — trading 21.9% below its estimated fair value. The current EV-to-EBIT is 56.26, which is 240% above median its 10-year median of 16.57 and 257.4% above the Healthcare Providers & Services industry median of 15.74. Oceania Healthcare's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Oceania Healthcare (ASX:OCA), the current EV-to-EBIT is 56.26 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oceania Healthcare (ASX:OCA) Overvalued in 2026?
Based on GuruFocus' analysis, Oceania Healthcare stock appears to be undervalued.
The current stock price of A$0.63 is trading 21.9% below its estimated GF Value™ of A$0.80.
GuruFocus considers Oceania Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:OCA:
EV-to-EBIT: 56.26 (240% above median its 10-year median of 16.57)
GF Value™: A$0.80 vs. price of A$0.63 (21.9% below fair value)
Industry Position: 257.4% above the Healthcare Providers & Services median (#424 of 471)
No single metric tells the full story. See the ASX:OCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oceania Healthcare Ltd owns and operates rest homes and retirement villages. The business activities of the group are operated through care operations, village operations, and other segments. The company generates maximum revenue from the care operations segment, which includes traditional care beds and care suites as well as the provision of accommodation, care, care packages, meals, and related services to aged care residents. Geographically, it operates throughout New Zealand. The company derives revenue from Rest homes, hospitals, dementia fees, and others.
39GF Score
Get the complete analysis for ASX:OCA
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OCA has been successfully added to your 
